Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115348) titled 'Analysis of Risk Factors for myelosuppression in Breast Cancer Patients undergoing chemotherapy and Construction of a predictive model' on Dec. 25, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Fuyang People's Hospital
Condition:
Bone marrow suppression caused by chemotherapy for malignant breast tumors
Intervention:
Myelosuppression group :None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-25
Target Sample Size: Myelosuppression group :58;non-myelosuppression group:58;
Countries of Recruitment:
China
To know more, visit https:/...